BioCentury
ARTICLE | Clinical News

Meridia sibutramine regulatory update

October 11, 2010 7:00 AM UTC

FDA ordered Abbott to withdraw obesity drug Meridia sibutramine in the U.S. The agency said Meridia's availability is not justified when comparing the "very modest weight loss" that people achieve on ...